EFFECTS OF REDUCING CONTINGENCY MANAGEMENT VALUES ON HEROIN AND COCAINE USE FOR BUPRENORPHINE- AND DESIPRAMINE-TREATED PATIENTS
Na minha lista:
KOSTEN, T., ET AL., EFFECTS OF REDUCING CONTINGENCY MANAGEMENT VALUES ON HEROIN AND COCAINE USE FOR BUPRENORPHINE- AND DESIPRAMINE-TREATED PATIENTS. ADDICTION, Vol. 98, no. 5 (2003), p. 665-671.
Ref.
119289
Localização:
SIIS R.696 Archivo
Palabras clave:
Antagonistas, Buprenorfina, Drogas ilegales, Drogodependencias, Efectos, Necesidades, Programas de desintoxicación, Recaída, Terapia, Tratamiento médico
Antagonistas, Buprenorfina, Drogas ilegales, Drogodependencias, Efectos, Necesidades, Programas de desintoxicación, Recaída, Terapia, Tratamiento médico
Registos relacionados: EFFECTS OF REDUCING CONTINGENCY MANAGEMENT VALUES ON HEROIN AND COCAINE USE FOR BUPRENORPHINE- AND DESIPRAMINE-TREATED PATIENTS
- DESIPRAMINE AND CONTINGENCY MANAGEMENT FOR COCAINE AND OPIATE DEPENDENCE IN BUPRENORPHINE MAINTAINED PATIENTS
- DESIPRAMINE TREATMENT FOR COCAINE DEPENDENCE IN BUPRENORPHINE- OR METHADONE-TREATED PATIENTS: BASELINE URINE RESULTS AS PREDICTOR OF RESPONSE
- DEPRESSION PREDICTS HIGHER RATES OF HEROIN USE ON DESIPRAMINE WITH BUPRENORPHINE THAN WITH METHADONE
- USE OF BUPRENORPHINE IN PREGNANCY: PATIENT MANAGEMENT AND EFFECTS ON THE NEONATE
- DESIPRAMINE, AMANTADINE, OR FLUOXETINE IN BUPRENORPHINE-MAINTAINED COCAINE USERS
- BUPRENORPHINE: HOW TO USE IT RIGHT